Background: To emphasize the effect of molecular markers on prognosis in endometrial cancer. in addition to the International Federation of Gynecology and Obstetrics (FIGO) 2009 classification. Methods: The records of 160 patients with endometrial cancer between 2008 and 2022 were retrospectively reviewed. Staging was done according to FIGO 2009 criteria. https://www.markymarkscott.com/product-category/9-30-volume/